Access to anti-retroviral drugs, male in Thailand

Thailand: Access to anti-retroviral drugs, male was 86.0% in 2024. ◆ Volatile

Latest (2024)
86.0%
Change on year
up 3.6%
World rank
30th
of 141 countries
All-time high
86.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Thailand, 2000–2024

0204060802000201220242000: 0 %2001: 0 %2002: 1 %2003: 2 %2004: 6 %2005: 11 %2006: 15 %2007: 19 %2008: 23 %2009: 27 %2010: 31 %2011: 35 %2012: 38 %2013: 43 %2014: 47 %2015: 53 %2016: 59 %2017: 63 %2018: 67 %2019: 70 %2020: 75 %2021: 77 %2022: 79 %2023: 83 %2024: 86 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, male in Thailand is 86.0%, measured in 2024. That is the highest value across all 25 years on record.

That represents a change of up 3.6% on the previous year and up 83.0% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Thailand peaked at 86.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places Thailand 30th out of 141 countries with data for 2024, putting it in the top quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Thailand, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Thailand, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 1.0%
2003 2.0% +100.0%
2004 6.0% +200.0%
2005 11.0% +83.3%
2006 15.0% +36.4%
2007 19.0% +26.7%
2008 23.0% +21.1%
2009 27.0% +17.4%
2010 31.0% +14.8%
2011 35.0% +12.9%
2012 38.0% +8.6%
2013 43.0% +13.2%
2014 47.0% +9.3%
2015 53.0% +12.8%
2016 59.0% +11.3%
2017 63.0% +6.8%
2018 67.0% +6.3%
2019 70.0% +4.5%
2020 75.0% +7.1%
2021 77.0% +2.7%
2022 79.0% +2.6%
2023 83.0% +5.1%
2024 86.0% +3.6%

Averages by decade

DecadeAverage LowestHighest Years
2000s 10.4% 0.0% 27.0% 10
2010s 50.6% 31.0% 70.0% 10
2020s 80.0% 75.0% 86.0% 5

Countries ranked near Thailand

  1. 27 Ecuador 87.0% compare
  2. 27 Haiti 87.0% compare
  3. 27 Slovenia 87.0% compare
  4. 30 Liberia 86.0% compare
  5. 30 Singapore 86.0% compare
  6. 30 Togo 86.0% compare

See the full ranking of 160 places →

More gender data for Thailand

All data for Thailand →

Frequently asked questions

What is access to anti-retroviral drugs, male in Thailand?
Access to anti-retroviral drugs, male in Thailand was 86.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Thailand?
The highest recorded value was 86.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Thailand?
The lowest recorded value was 0.0% in 2000.
How does Thailand rank for access to anti-retroviral drugs, male?
Thailand ranks 30th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Thailand?
Over the last ten years it is up 83.0%. The long-run trend across the full record is volatile.
Where does this Thailand data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Thailand. Statizoid, drawing on UNAIDS estimates. Retrieved 10 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/thailand/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/thailand/">Access to anti-retroviral drugs, male in Thailand</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.